GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (FRA:7UX) » Definitions » Short Interest

Spago Nanomedical AB (FRA:7UX) Short Interest


View and export this data going back to 2021. Start your Free Trial

What is Spago Nanomedical AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Spago Nanomedical AB's Short Interest

For the Biotechnology subindustry, Spago Nanomedical AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spago Nanomedical AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's Short Interest falls into.


Spago Nanomedical AB (FRA:7UX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (FRA:7UX) » Definitions » Short Interest
Comparable Companies
XSAT:PHAL OSTO:PILA OSTO:CYXO OSTO:ASAP XSAT:ALTE OSTO:DIABIO OSTO:REDW OSTO:PHARM OSTO:FLUI OSTO:MODTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
SPAGO:Sweden
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Website
https://www.spagonanomedical.se
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (FRA:7UX) Headlines

No Headlines